SEARCH RESULTS FOR: "Tag: AXGT"
REFINE YOUR SEARCH:
RECENT
Last Month(1)
ARTICLES/BLOGS
2019(4)
CATEGORIES
Analyst Update(3)
Buzz Stocks(1)
Intraday Option Activity(1)
Baird: Buy This Biotech Before Data Release
https://www.schaeffersresearch.com/content/news/2019/08/12/baird-buy-this-biotech-before-data-release
8/12/2019 2:59 PM
Axovant Gene Therapies Ltd (NASDAQ:AXGT) is getting a boost from Baird today -- bucking the broad-market trend lower -- after the analyst upgraded the biotech to "outperform" from "neutral," predicti...
Options Heat Up on "Undervalued" Drug Stock
https://www.schaeffersresearch.com/content/options/2019/06/21/options-heat-up-on-undervalued-drug-stock
6/21/2019 10:34 AM
The shares of Axovant Gene Therapies Ltd (NASDAQ:AXGT) are soaring today, thanks to some upbeat analyst attention. Specifically, SVB Leerink initiated coverage of AXGT stock with an "outperform" rati...
Jefferies Calls Bottom on Gene Therapy Stock After Huge Sell-Off
https://www.schaeffersresearch.com/content/news/2019/06/12/jefferies-calls-bottom-on-gene-therapy-stock-after-huge-sell-off
6/12/2019 10:30 AM
Axovant Sciences Ltd (NASDAQ:AXGT) has seen its stock fall from the mid-$30 range to yesterday's close of $3.94, even after positive data for its Parkinson's treatment. However, Jefferies referred to...
Penny Stock Pops on Parkinson's Treatment Progress
https://www.schaeffersresearch.com/content/news/2019/03/11/penny-stock-pops-on-parkinsons-treatment-progress
3/11/2019 9:43 AM
The shares of biotechnology concern Axovant Sciences Ltd (NASDAQ:AXGT) are up 54% at $2.28 in early trading after announcing successful phase 2 trial results for its Parkinson's treatment, AXO-Lenti...
PEOPLE ALSO SEARCH FOR
AXGT
Welcome to Schaeffer's Investment Research! We are a privately held provider of stock and options trading recommendations, options education, and market commentary, headquartered in Cincinnati, Ohio. Founded in 1981 by industry pioneer Bernie Schaeffer, we've since become a trusted source of research and analysis for individual investors and major financial media outlets alike.
More About
Schaeffer's
Contact
Us
Partner Center